The recent new breakthrough discovery of CD4 T Cells expressing high CD26 was very encouraging.
https://www.sciencedaily.com/releases/2017/12/171220091745.htm
Is the company also conducting specific work on CD4 T Cells as part of their peptide vaccine validation research or is the focus solely on CD8 T Cells? If so, are you able to elaborate as to why?
Thanks,
Tony
The recent new breakthrough discovery of CD4 T Cells expressing...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 58344 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |